The Benefits of Stereotactic Radiosurgery (SRS) for Brain Tumor Patients

A recent clinical study presented at the American Society for Radiation Oncology (ASTRO) annual meeting, showed that adult cancer patients younger than 50 with a limited number of brain metastases have improved overall survival after stereotactic radiosurgery.

The study goes on to highlight the benefits of stereotactic radiosurgery for metastatic brain tumors including the minimal exposure of radiation to nearby healthy tissue. Our center treats malignant and benign tumors with SRS using CyberKnife® technology to precisely target tumors with high-dose radiation. This approach is particularly advantageous for brain tumor patients because unlike most radiosurgery systems, the CyberKnife does not require an invasive head frame.

Radiosurgery is a widely accepted treatment for a single metastatic brain tumor that cannot be safely removed surgically. It’s also used frequently for patients with multiple metastatic tumors, a condition that usually prevents surgery.

Patients who receive CyberKnife treatment are treated within 1-5 treatment sessions and have little to no recovery time. For more information on the benefits of CyberKnife for brain tumors, visit our conditions treated page or contact us.

This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.